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January 2011248 Abstractsin five patients at a median follow-up of 26 months (range, 1-87; mean, 29
months). One patient’s procedure was complicated by aphasia and contralat-
eral hemiplegia. This patient also subsequently developed a contralateral
stroke and died 4 months after the procedure. An additional patient devel-
oped ipsilateral TIAs 3 weeks after stenting and subsequently underwent an
extracranial-to-intracranial bypass, with no further symptoms. There was no
apparent symptomatic in-stent restenosis, although50% in-stent restenosis
was noted in two patients on follow-up.
Comment: Stenting of the ECA is an unusual procedure. (The article
actually has more authors, 14, than patients, 12!) The results are certainly
not a mandate for ECA stenting for apparently symptomatic ECA stenosis.
However, there are also no compelling data for open revascularization of the
ECA. Revascularization of the ECA, whether by endovascular or open
surgical treatment, is supported by nothing more than individual case series
and is never likely to be supported by anything other than case series.
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Conclusion: Graft-related complications and reinterventions after en-
dovascular aneurysm repair (EVAR) are more common in older patients and
in patients with larger aneurysms.
Summary: The authors sought to determine baseline factors that were
associated with graft-related complications and reinterventions after EVAR.
The analysis consisted of patients randomized to elective EVAR in the EVAR
1 or 2 trials. Patients were followed-up for serious graft-related complica-
tions, defined as graft rupture, proximal or distal graft migration, proximal or
distal type 1 endoleak, type 3 endoleak (loss of structural integrity, modulardisconnection, stent fracture, fabric tear or holes), graft kinking or throm-
bosis, graft infection, renal infarction, unsuccessful deployment, and con-
version to open repair for any complication, including type 2 endoleak or
endotension. Patients were also followed-up for reintervention. Reinterven-
tion criteria were not specified in the original EVAR trial protocols, and
reinterventions were based on local decisions. Cox regression analysis was
used to investigate if prespecified baseline factors were associated with time,
serious complication, or reintervention.
A total of 756 patients had elective EVAR and were followed-up for a
mean of 3.7 years. There were 179 serious graft complications (rate, 6.5/
100 person-years) and 114 reinterventions (rate, 3.8/100 person-years).
The highest rates were during the first 6 months, with apparent increased
rates again after 2 years. Multivariable analysis indicated graft-related com-
plications increased with larger initial aneurysm diameter (P  .001) and
older age (P .040). Some evidence suggested that patients treated with the
Excluder device (W.L. Gore & Associates, Flagstaff, Ariz) had lower rates of
complications and reinterventions compared with other graft types. Patients
with larger common iliac diameters also appeared to experience higher
complication rates (P  .011).
Comment: The association of increasing aneurysm diameter and in-
creasing age with complication and reintervention rates after EVAR stand
out as the most telling findings in this study. The results, however, really
cannot be construed to justify EVAR in younger patients with small abdom-
inal aortic aneurysms, because rupture rates are low in these patients (Powell
JT, Br J Surg 2007;94:702-8; and Lederle FA, N Engl J Med 2002;346:
1437-44). It also important to note that the inclusion criteria for patients in
the EVAR 1 and 2 trials were relatively strict. Relaxing anatomic selection
criteria undoubtedly will result in higher complication and reintervention
rates. Appropriate selection of anatomically suitable patients for EVAR
remains crucial to the long-term success of the procedure.
